Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2020 / Cilt: 54 - Sayı: 1

Dyslipidemia in Lichen Planus: A Case-control Study

Pages
62–66
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No significant differences between LP patients and controls wereobserved with the average age, sex, tobacco consumption and hypertension.Conclusion: This prospective case-control study demonstrated that dyslipidemia was more common among patients with LP.Physicians should be aware of this association and consider screening them for dyslipidemia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Lichen planus (LP) is a chronic inflammatory disease that affects the skin, mucous membranes, scalp and nails.
📊
Key Findings & Data:This study aims to conduct a prospective case-control study to investigate the association between LP and dyslipidemia.Methods: This study was conducted on 49 patients with LP (mucosal or cutaneous) and 99 healthy controls.
💡
Conclusion & Impact:No significant differences between LP patients and controls wereobserved with the average age, sex, tobacco consumption and hypertension.Conclusion: This prospective case-control study demonstrated that dyslipidemia was more common among patients with LP.Physicians should be aware of this association and consider screening them for dyslipidemia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: Lichen planus (LP) is a chronic inflammatory disease that affects the skin, mucous membranes, scalp and nails. It hasbeen reported that diabetes mellitus and dyslipidemia prevalence were higher in patients with LP. However, most of these reportswere retrospective, database search, which included patients who were on lipid-lowering drugs. This study aims to conduct a prospective case-control study to investigate the association between LP and dyslipidemia.Methods: This study was conducted on 49 patients with LP (mucosal or cutaneous) and 99 healthy controls. All patients weresubjected to clinical and histological examination, whereas controls were subjected to clinical examination. The variables analyzedwere age, sex, tobacco consumption, hypertension, lipid profiles and fasting blood glucose.Results: Serum levels of triglycerides, total cholesterol and LDL cholesterol were higher in patients with LP. However, there wasno significant difference between patients with LP and controls. No significant differences between LP patients and controls wereobserved with the average age, sex, tobacco consumption and hypertension.Conclusion: This prospective case-control study demonstrated that dyslipidemia was more common among patients with LP.Physicians should be aware of this association and consider screening them for dyslipidemia.

🔖

Cite This Article

ÖZKUR, E., UĞURER, E., ALTUNAY, İ. K. (2020). Dyslipidemia in Lichen Planus: A Case-control Study. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 54 - Sayı: 1, 62–66. https://ajindex.com/articles/363721

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med 2012;366:723–32
  2. Brown RS, Bottomley WK, Puente E, Lavigne GJ. A retrospective evaluation of 193 patients with oral lichen planus. J Oral Pathol Med 1993;22:69–72
  3. Silverman S Jr, Gorsky M, Lozada-Nur F. A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association. Oral Surg Oral Med Oral Pathol 1985;60:30–4
  4. Thorn JJ, Holmstrup P, Rindum J, Pindborg JJ. Course of various clinical forms of oral lichen planus. A prospective follow-up study of 611 patients. J Oral Pathol 1988;17:213–8
  5. Gorouhi F, Davari P, Fazel N. Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. ScientificWorldJournal 2014;2014:742826
  6. McCartan BE, Healy CM. The reported prevalence of oral lichen planus: a review and critique. J Oral Pathol Med 2008;37:447–53
  7. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001;303:33–9
  8. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007;190:1–9
  9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97
  10. Baykal L, Arıca DA, Yaylı S, Örem A, Bahadır S, Altun E, et al. Prevalence of Metabolic Syndrome in Patients with Mucosal Lichen Planus: A Case-Control Study. Am J Clin Dermatol 2015;16:439– 45
  11. Lai YC, Yew YW, Schwartz RA. Lichen planus and dyslipidemia: a systematic review and meta-analysis of observational studies. Int J Dermatol 2016;55:e295–e304
  12. Saleh N, Samir N, Megahed H, Farid E. Homocysteine and other cardiovascular risk factors in patients with lichen planus. J Eur Acad Dermatol Venereol 2014;28:1507–13
  13. Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A. Pathogenesis of oral lichen planus-a review. J Oral Pathol Med 2010;39:729–34
  14. Zhou XJ, Sugerman PB, Savage NW, Walsh LJ, Seymour GJ. Intraepithelial CD8+ T cells and basement membrane disruption i